Axsome Therapeutics, Inc. (NASDAQ:AXSM) is a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders. The company has been gaining significant ...

In conclusion, Axsome Therapeutics presents a compelling investment case with its strong commercial performance and promising pipeline. According to InvestingPro's Fair Value analysis, the stock ...

In conclusion, Axsome Therapeutics presents a compelling investment case with its strong commercial performance and promising pipeline. According to InvestingPro's Fair Value analysis, the stock ...

Axsome Therapeutics, Inc. NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

House GOP Leader Rep. Lisa Demuth, R-Cold Spring, is sworn in after being voted in by only Republicans as speaker on the first day of the 2025 Legislature. Democrats' desks were empty in protest ...

Two attorneys who quit their longtime firm have asked a court to enjoin their former employer from interfering. The departing lawyers say their former firm has a long history of meddling with ...

A coalition of Democratic state attorneys general filed a federal lawsuit on Tuesday to stop President Trump's executive order that seeks to eliminate birthright citizenship. Mr. Trump invoked ...

NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders ...